Hunan Hansen Pharmaceutical Hits Day High with 10.04% Surge

Hunan Hansen Pharmaceutical Co. has experienced a significant surge in its stock price, gaining 10.04% on August 21, 2026. The stock reached an intraday high of CNY 10.19, marking a notable performance compared to the China Shanghai Composite, which only increased by 0.04% on the same day. Over the past week, Hunan Hansen has shown remarkable growth, with a 39.21% increase, while the broader market has declined by 0.56%. The company's performance over the past month is even more impressive, with a 67.05% rise, significantly outpacing the China Shanghai Composite's 1.06% gain. Despite a challenging long-term outlook, Hunan Hansen's recent financial metrics indicate positive trends. The company reported a net profit of CNY 153.11 million, reflecting a robust growth rate of 53.5%. Additionally, the operating cash flow reached its highest level at CNY 188.12 million. With a market capitalization of CNY 3,683 million, Hunan Hansen continues to navigate the pharmaceuticals and biotechnology sector with a return on equity of 9.23% and a price-to-earnings ratio of 12.00.